Blood Protein Therapeutics: It All Starts with the Plasma
The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
Myths and Facts: Venomous Snakebites
Although venomous snakebites are rare in the U.S. compared to other countries, they are still medical emergencies that need to be treated with today’s safe and effective methods.
Narrative Medicine: How Stories of Illness Affect Caregiving
A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.
Hope for Hepatitis C
Screening and new treatments offer a high cure rate for those affected by hepatitis C, which was once a grave disease.
Zoonotic Diseases: An Emerging Global Health Challenge
Although noncommunicable diseases are the leading cause of morbidity and mortality in most developed nations, zoonotic diseases remain a major public health concern.
The New Therapeutic Renaissance for Patients with Rare Bleeding Disorders
As it has since the first commercially produced factor VIII concentrate transformed the lives of U.S. hemophilia A patients, innovation is still the life-blood of this industry.
Data Collection: A New Regime
An ongoing revolution in healthcare ties data and reimbursement with the demand for analytics that provide insight into a variety of areas.
Irreproducible Research: The Need for Study Validation
Changes are needed in the way scientific research is currently conducted to ensure its legitimacy and efficacy.
Myths and Facts: Alzheimer’s Disease
Government and researchers continue to pursue plans and studies to gain a greater understanding of this devastating and deadly disease in order to prevent, treat and, ultimately, cure it.
BabyBIG: Definitive Early Immunotherapy for Infant Botulism
Explore the history and trace the development of BabyBIG, the life-saving immunotherapy for infant botulism.
